Back

Transcatheter aortic valve implantation: efficacy, safety and mortality at 30-days to 1-year from a nationwide eight year registry

28 August 2016 (15:35 - 15:42)
Organised by:
Congress Presentation Part of: Current data on TAVI outcomes Aortic Disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Pedro Canas da Silva

Santa Maria Hospital - CHULN, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry
Doctor P. Canas da Silva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Impact of residual coronary artery disease on patients undergoing TAVI: a multicenter study
Doctor S. Taha (Assiut, EG)
Abstract Slides
Presentation thumbnail
Role of clopidogrel loading dose in patients undergoing transcatheter aortic valve implantation: results from the BRAVO-3 randomized trial
Mr V. Nijenhuis (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Effect of body mass index on mortality after transcatheter aortic valve implantation: J-shaped curve.
Ms R. GONZALEZ FERREIRO (Vigo, ES)
Abstract
Presentation thumbnail
Acute kidney injury following transcatheter aortic valve implantation: does it affect long-term outcomes?
Doctor A. Bacelar (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Current data on TAVI outcomes

The Event

Event poster

ESC Congress 2016

28 August 2016 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources